NASDAQ : UTMD
-$5.01 (-7.24%)
NASDAQ
Kevin L. Cornwell
Medical - Instruments & Supplies
Healthcare
UTMD
155
US
USD
0.00
28.64
26.15
24.94
0.36
$38.52M
5.44
1.70
15.70
4.09
$3.48
$11.29M
28.90%
35.79%
9.13%
8.72%
19.45
-1.62
-1.62
4/5
0 Analysts
%
35.98
7/9
$96.87M
$124.38M
$4.01M
$13.43M
$133.11M
3.55
8.13
28.64
9.13%
7.23%
4.92%
5.91%
$53.82
193 days
| Name | Title |
|---|---|
| Brian L. Koopman | Principal Financial Officer, Accounting Manager & Controller |
| Kevin L. Cornwell | Chairman, Chief Executive Officer, President & Secretary |
| Marcena H. Clawson | Vice President of Corporate Sales |
| Mark L. Fox | Vice President of Marketing |
No votes yet today — be the first to share your view!
About Utah Medical Products, Inc. (NASDAQ:UTMD) Stock
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), an ... d feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
2026-07-23 09:00:00
SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
Utah Medical Products, Inc. Announces Quarterly Dividend
2026-05-05 10:00:00
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
2026-04-29 13:31:13
UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.
Frequently Asked Questions
What is the current Utah Medical Products, Inc. (UTMD) stock price?
Utah Medical Products, Inc.(NASDAQ:UTMD) stock price is $64.18 in the last trading session. During the trading session, UTMD stock reached the peak price of $75.75 while $53.66 was the lowest point it dropped to. The percentage change in UTMD stock occurred in the recent session was --7.24% while the dollar amount for the price change in UTMD stock was -$5.01.
UTMD's industry and sector of operation?
The NASDAQ listed UTMD is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
Who are the executives of UTMD?
Brian L. Koopman
| Principal Financial Officer, Accounting Manager & Controller
Kevin L. Cornwell
| Chairman, Chief Executive Officer, President & Secretary
Marcena H. Clawson
| Vice President of Corporate Sales
Mark L. Fox
| Vice President of Marketing
|
How many employees does UTMD have?
Number of UTMD employees currently stands at 155. UTMD operates from 7043 South 300 West, Midvale, UT 84047-1048, US.
Link for UTMD official website?
Official Website of UTMD is: https://www.utahmed.com
How do I contact UTMD?
UTMD could be contacted at phone #801 566 1200 and can also be accessed through its website. UTMD operates from 7043 South 300 West, Midvale, UT 84047-1048, US.
How many shares of UTMD are traded daily?
The average number of UTMD shares traded daily for last 3 months was 15.35K.
What is the market cap of UTMD currently?
The market value of UTMD currently stands at $204.35M with its latest stock price at $64.18